A Long-Term Clinical Study of SFPP in Patients with Osteoarthritis

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221798

Enrollment

200

Registered

2012-05-25

Start date

2012-05-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Interventions

investigational material(s) Generic name etc : SFPP INN of investigational material : Therapeutic category code : 264 Analgesics, anti-itchings, astrigents and anti-inflammatory agents Dosage and Adm

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Outpatient - Patients who require long-term NSAIDs treatment. etc.

Exclusion criteria

Exclusion criteria: - Patients who are scheduled for surgery during the study period. - Having critical hepatic disease, renal disease, heart disease and hematologic disease and malignant tumor. etc.

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
Efficacy	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026